Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.77 USD | +0.80% | -7.59% | +19.81% |
Financials (USD)
Sales 2024 * | 25.55M | Sales 2025 * | 70.34M | Capitalization | 369M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -46M | EV / Sales 2024 * | 14.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
-6.17
x | P/E ratio 2025 * |
-9.84
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.08% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +0.80% | ||
1 week | -7.59% | ||
Current month | +25.92% | ||
1 month | +29.16% | ||
3 months | +75.75% | ||
6 months | +137.67% | ||
Current year | +19.81% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 8.77 | +0.80% | 106 519 |
24-05-20 | 8.7 | +0.35% | 326,138 |
24-05-17 | 8.67 | -5.25% | 162,757 |
24-05-16 | 9.15 | +0.55% | 177,314 |
24-05-15 | 9.1 | -4.11% | 269,063 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.81% | 369M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- VRCA Stock